Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Manufacturing source : Www.eyegatepharma.com save search
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
Published: 2022-02-01 (Crawled : 12:00) - eyegatepharma.com
KPRX | $0.485 -1.08% -1.07% 97K
|
Manufacturing
|
| O: 4.77%
H: 3.2%
C: -1.25%
als
Kiora Pharmaceuticals to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference
Published: 2022-01-05 (Crawled : 12:00) - eyegatepharma.com
KPRX | $0.485 -1.08% -1.07% 97K
|
Manufacturing
|
| O: -4.42%
H: 1.85%
C: -3.7%
als conference
Kiora Pharmaceuticals Appoints David Hollander, MD, MBA, to its Board of Directors
Published: 2021-12-15 (Crawled : 12:00) - eyegatepharma.com
KPRX | $0.485 -1.08% -1.07% 97K
|
Manufacturing
|
| O: -4.76%
H: 0.83%
C: -25.2%
AERI | $15.25 0.0%
|
Health Technology
|
| O: 3.35%
H: 0.0%
C: 0.0%
als
Kiora Reports KIO-101 is Safe and Tolerable; Topline Data Supports Advancing KIO-101 to a Phase 2 Study in Patients with Dry Eye Disease
Published: 2021-12-14 (Crawled : 12:00) - eyegatepharma.com
KPRX | $0.485 -1.08% -1.07% 97K
|
Manufacturing
|
| O: -8.7%
H: 0.0%
C: 0.0%
kio-101 dry eye phase 2 eye eye disease disease topline
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.